Macerat concentré de bourgeons de bouleau verruqueux
Food supplement declared in France, declaration No 2024-4-1463, decision dated 28 April 2024
Macerat concentré de bourgeons de bouleau verruqueux, from HOSPITAL BEATRICE, is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Betula pendula 0.15 g per day. 1 rule of use applies to its ingredients (limits and warnings).
- Brand
- not provided
- Food business operator placing the product on the market
- HOSPITAL BEATRICE
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Dropper
- Daily dose
- 1,5 ml
- Directions for use
- Adultes et adolescents : 2 à 10 gouttes 3 fois par jour pures ou diluées
- Not recommended (according to the manufacturer)
- Breastfeeding women, Children (under 12), Pregnant women
- Objectives stated by the manufacturer (these are not authorised claims)
- Respiratory tract, Joints
Declaration 326610, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Betula pendula Roth | Bourgeon | Macérât hydroalcoolique | 0.15 g |
Additives
E422
Other ingredients
eau de source, Alcool
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Label warnings
- Ne pas dépasser la dose journalière indiquée.- Ne se substitue pas à une alimentation variée et équilibrée et un mode de vie sain.- Déconseillé aux personnes souffrant d'allergie aux dérivés salicylés et d'intolérance aux anti-inflammatoires non-stéroïdiens.- Déconseillé aux personnes sous traitement anti-coagulant.- Tenir hors de portée des jeunes enfants.- Consultez votre médecin/thérapeute avant toute prise d'un complément alimentaire.
Regulatory points
- Conditions légales
Betula pendula Roth: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux personnes souffrant d'allergie aux dérivés salicylés
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Betula pendula Roth
Read the warning, when it applies and the studies cited
Birch
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have kidney or cardiovascular disorders (Brinker 2010; Bradley 2006; ESCOP 2003; Blumenthal et al. 1998).
Sources cited by Health Canada (4)
- Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Riggins C, Rister R, editors. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. Austin (TX): American Botanical Council; 1998.
- Bradley PR, editor. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 2. Bournemouth (UK): British Herbal Medicine Association; 2006.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (Brinker 2010).
Sources cited by Health Canada (1)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- Macérat concentré de bourgeons de bouleau verruqueux Méristème, declared in 2024 : different composition: 1 ingredient(s) added, 1 missing
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Macerat concentré de bourgeons de bouleau verruqueux: composition and regulation”, https://compoatlas.com/en/supplements/products/326610-macerat-concentre-de-bourgeons-de-bouleau-verruqueux, updated 15 November 2026.